性能参数

产品名称

Taurochenodeoxycholic acid (12-Deoxycholyltaurine)

规格

10mM*1mLinDMSO 50mg

货号

GOY-Y2709

 含量

>98.00%

CAS

516-35-8

别名

N/A

化学名

N/A

分子式

C26H45NO6S

分子量

分子量 499.7

溶解度

DMSO : ≥ 25 mg/mL (50.03 mM)

储存条件

Store at RT

General tips

用途

仅供科研

价格

电询

详细内容

Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.

Studies have suggested that taurochenodeoxycholic acid as a signaling molecule shows obvious anti-inflammatory and immune regulation properties. Taurochenodeoxycholic acid dramatically improves the apoptosis rate of NR8383 cells in a concentration-dependent manner. In the meantime, PKC mRNA levels and activities are significantly augmented by taurochenodeoxycholic acid treatments. In addition, JNK, caspase-3 and caspase-8 mRNA expression levels and activities are increased by taurochenodeoxycholic acid[1].

Taurochenodeoxycholic acid in dosages of 0.05 and 0.1g/kg can decrease the pulmonary coefficient in the model mice, taurochenodeoxycholic acid in dosages of 0.05 and 0.1g/kg reduce the pathological damages on their lungs; it can decrease the expression levels of TNF-α and TIMP-2 in pulmonary tissues in the pulmonary fibrosis mice, the expression level of MMP-9 increases, while it has no significant effects on MMP2[2]. Taurochenodeoxycholic acid significantly normalizes the clinical inflammatory parameters, prevented indomethacin-induced increases in the biliary contents of secondary bile acids and hydrophobicity index, and tended to attenuate the intestinal inflammation[3]. Taurochenodeoxycholic acid significantly suppresses paw swelling and polyarthritis index, increases the loss body weight and index of thymus and spleen, and amends radiologic changes in AA rats. The overproduction and mRNA expression of TNF-α, IL-1β and IL-6 are remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats[4].

[1]. Wang X, et al. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway. Eur J Pharmacol. 2016 Sep 5;786:109-15. [2]. Zhou C, et al. The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice. Pak J Pharm Sci. 2013 Jul;26(4):761-5. [3]. Uchida A, et al. Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation. Am J Physiol. 1997 May;272(5 Pt 1):G1249-57. [4]. Liu M, et al. Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats. Int Immunopharmacol. 2011 Dec;11(12):2150-8.

1,10-菲罗啉，一水 AR,98%  正十八硫醇  97%

1,10-菲罗啉，一水 ACS，99%  1,8-辛二硫醇 98%

乙酸钾 AR,99.0%  1,8-辛二硫醇 ≥97%, Kosher

乙酸钾 CP,85.0%  1,3-丙二硫醇 98%

乙酸钾 99.98% metals basis  1,5-戊二硫醇 96%

乙酸钾,ACS,99%  溴乙酸苯酯 98%

Spectinomycin (hydrochloride hydrate)1g 5g 10g>98.00%Cas No. 22189-32-8C14H24N2O7 ? 2HCl [5H2O]

Sterculic Acid methyl ester1mg 5mg 10mg>98.00%Cas No. 3220-60-8C20H36O2

Sulfaclozine sodium100mg 200mg 500mg>98.00%Cas No. 23307-72-4C10H8ClN4NaO2S

Sulfacetamide100mg 200mg 500mg>98.00%Cas No. 144-80-9C8H10N2O3S

Sulbentine (Dibenzthione)10mM*1mLinDMSO 50mg 100mg>98.00%Cas No. 350-12-9C17H18N2S2

Sulbenicillin disodium10mM*1 mL in Water 25mg 50mg>98.00%Cas No. 28002-18-8C16H16N2Na2O7S2

Sulfamethazine10mM (in 1mL DMSO) 10mg 100mg>98.00%Cas No. 57-68-1C12H14N4O2S